Lv1
30 积分 2025-05-05 加入
Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma
7小时前
已完结
Interpretive consistency of a qualitative 68Ga-PSMA PET framework for treatment response assessment in hepatocellular carcinoma: a head-to-head comparison with cross-sectional imaging
7小时前
已完结
The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms
1个月前
已完结
Prognostic value of LI-RADS category on gadoxetic acid–enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas
1个月前
已完结
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT
1个月前
已完结
Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma
1个月前
已完结
Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma
1个月前
已完结
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
2个月前
已完结
MRI imaging features for evaluating the efficacy and prognosis of TACE combined with targeted immunotherapy in unresectable hepatocellular carcinoma
2个月前
已完结
Precision Risk Stratification in Hepatocellular Carcinoma: Clinical Relevance of CatBoost-based Prediction Following TACE
2个月前
已完结
皖公网安备34019202002308
